These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 12034168

  • 1. Adenovirus-mediated CD40Ig expression attenuates chronic vascular rejection lesions in an aorta allotransplantation model.
    Mathieu P, Guillot C, Gerdes C, Buzelin F, Lowenstein P, Castro M, Soulillou JP, Anegon I.
    Transplant Proc; 2002 May; 34(3):743-4. PubMed ID: 12034168
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of leflunomide and cyclosporine on aortic allograft chronic rejection in the rat.
    MacDonald AS, Sabr K, MacAuley MA, McAlister VC, Bitter-Suermann H, Lee T.
    Transplant Proc; 1994 Dec; 26(6):3244-5. PubMed ID: 7998130
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition of intimal hyperplasia in rat aortic allografts with cyclosporine.
    Stoltenberg RL, Geraghty J, Steele DM, Kennedy E, Hullett DA, Sollinger HW.
    Transplantation; 1995 Nov 15; 60(9):993-8. PubMed ID: 7491707
    [Abstract] [Full Text] [Related]

  • 6. Prolonged blockade of CD40-CD40 ligand interactions by gene transfer of CD40Ig results in long-term heart allograft survival and donor-specific hyporesponsiveness, but does not prevent chronic rejection.
    Guillot C, Guillonneau C, Mathieu P, Gerdes CA, Ménoret S, Braudeau C, Tesson L, Renaudin K, Castro MG, Löwenstein PR, Anegon I.
    J Immunol; 2002 Feb 15; 168(4):1600-9. PubMed ID: 11823487
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Blockade of the CD28/B7 and CD40/CD40L costimulatory pathways does not ameliorate chronic rejection in a mouse aortic allograft model of direct antigen presentation.
    Tang JL, Woodward JE, Subbotin V, Logar AJ, Sun H, Valdivia LA, Schaefer AT, Zottola LB, Peach R, Fung JJ, Rao AS.
    Transplant Proc; 2001 Feb 15; 33(1-2):382. PubMed ID: 11266872
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The role of alloantigen-independent factors in transplant arteriosclerosis.
    Kouwenhoven EA, Marquet RL, Bonthuis F, IJzermans JN, de Bruin RW.
    Transplant Proc; 1997 May 15; 29(3):1721-2. PubMed ID: 9142246
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Histologic modification by cryopreservation in rat aortic allografts.
    Motomura N, Imakita M, Yutani C, Takamoto S, Kitoh Y, Tsuji T, Kawashima Y, Wada Y, Oka T.
    Ann Thorac Surg; 1995 Aug 15; 60(2 Suppl):S168-71. PubMed ID: 7646152
    [Abstract] [Full Text] [Related]

  • 19. Targeted gene therapy with CD40Ig to induce long-term acceptance of liver allografts.
    Chang GJ, Liu T, Feng S, Bedolli M, O'rourke RW, Schmidt G, Roberts JP, Stock PG.
    Surgery; 2002 Aug 15; 132(2):149-56. PubMed ID: 12219005
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.